Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 590-599

  Shaffer, Nathan ^a,b   Roongpisuthipong, Anuvat ^a,b   Siriwasin, Wimol ^a,b   Chotpitayasunondh, Tawee ^a,b   Chearskul, Sanay ^a,b   Young, Nancy L ^a,b   Parekh, Bharat ^a,b   Mock, Philip A ^a,b   Bhadrakom, Chaiporn ^a,b   Chinayon, Pratharn ^a,b   Kalish, Marcia L ^a,b   Phillips, Susan K ^a,b   Granade, Timothy C ^a,b   Subbarao, Shambavi ^a,b   Weniger, Bruce G ^a,b   Mastro, Timothy D ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NATURAL KILLER CELL; PERINATAL INFECTION; PREMATURITY; PRIORITY JOURNAL; T LYMPHOCYTE; THAILAND; VAGINAL DELIVERY; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; GESTATIONAL AGE; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; LYMPHOCYTES; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; RISK-TAKING; THAILAND; VIRAL LOAD;

EID: 0033377940     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314641     Document Type: Article

References (47)

1. 1. Weniger BG, Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994;8(suppl 2):S13-8.
2. 2. Mason CJ, Markowitz LE, Kitsiripornchai S, et al. Declining prevalence of HIV-1 infection in young Thai men. AIDS 1995;9:1061-5.
3. 3. Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996;335:197-303.
4. 4. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-I Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291-3.
5. 5. Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-I in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506-10.
6. 6. Connor EM, Sperling RS, Gelber RD, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994;331:1173-80.
7. 7. Thomas PA, Weedon J, Krasinski K, et al. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994; 13:489-95.
8. 8. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type I from mother to child. N Engl J Med 1996;334:1617-23.
9. 9. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-I transmission: the French Cohort Study; 7 years of follow-up observation. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8: 188-94.
10. 10. Bryson YJ. Perinatal HIV-I transmission: recent advances and therapeutic interventions. AIDS 1996;10(suppl 3):S33-42.
11. 11. Dunn DT, Newell ML, Mayaux MJ, et al. Mode of delivery and vertical transmission of human immunodeficiency virus type I: a review of prospective studies. J Infect Dis 1994;7:1064-6.
12. 12. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type I RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92: 12100-4.
13. 13. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91:8037-41.
14. 14. Dickover RE, Garatly EM, Herman SA, et al. Identification of levels of maternal HIV-I RNA associated with risk of perinatal transmission. JAMA 1996;275:599-605.
15. 15. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
16. 16. Cao Y, Krogstad P, Korber B, et al. Maternal HIV-I viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997;3:549-52.
17. 17. Thea DM, Steketee RW, Pliner V, et al. The effect of maternal viral load on the risk of perinatal transmission of HIV-I. AIDS 1997;11:437-44.
18. 18. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. J Infect Dis 1997;175:172-5.
19. 19. Burns DN, Landesman S, Wright DJ, et al. Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type I. J Infect Dis 1997;175:1206-10.
20. 20. Siriwasin W, Shaffer N, Roongpisuthipong A, et al. HIV prevalence, risk factors, and partner serodiscordance among pregnant women, Bangkok, Thailand. JAMA 1998;280:49-54.
21. 21. Schochetman G, Subbarao S, Kalish ML. Methods for studying genetic variation of the human immunodeficiency virus (HIV). In: Adolph KW, ed. Viral genome methods. Boca Raton, FL: CRC Press, 1996:25-41.
22. 22. Michael N, Robb M, Birx D, et al. Performance of the Amplicor HIV-I Monitor test and a modified HIV-I Monitor test on HIV-I subtypes A to F (abstract 279). In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
23. 23. Parekh B, Phillips S, Granade TC, Baggs J, Hu D, Respess R. Impact of HIV-I subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15:133-42.
24. + T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Morb Mortal Wkly Rep 1997; 46(RR-2):1-29.
25. 25. Pau CP, Lee-Thomas S, Auwanit W, et al. Highly specific V-3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993;7:337-40.
26. 26. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12):1-19.
27. 27. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-I. N Engl J Med 1992;327:1246-7.
28. 28. Kuhn L, Abrams EJ, Matheson PB, et al. Timing of maternal-infant transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997;11:429-35.
29. 29. Chaisilwattana P, Chuachoowong R, Siriwasin W, et al. Chlamydial and gonococcal cervicitis in HIV-seropositive and HIV-seronegative pregnant women in Bangkok. Sex Transm Dis 1997;24:495-502.
30. 30. Cleveland WS. Robust locally weighted regression and smoothing scatter-plots. J Am Stat Assoc 1979;74:829-36.
31. 31. Deubner DC, Wilkinson WE, Helms MJ, Tyroler HA, Hames CG. Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans County, Georgia. Am J Epidemiol 1980;112:135-43.
32. 32. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-72.
33. 33. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan. Ivory Coast. JAMA 1994;272:462-6.
34. 34. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
35. 35. St. Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853-9.
36. 36. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 1998;12:301-8.
37. 37. Pitt J, Brambilla D, Reichelderfer P, et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study. J Infect Dis 1997;175:567-75.
38. 38. Moretta L, Ciccone E, Mingari MC, et al. Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994;55:341-80.
39. 39. Gumperz J, Parham P. The enigma of the natural killer cell. Nature 1995; 378:245-8.
40. 40. Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994;1:125-33.
41. + natural killer cell subset during HIV infection. Cytometry 1995;22:10-15.
42. 42. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type I: association with prematurity or low anti-gp120. Lancet 1989;2:1351-4.
43. 43. Goedert JJ, Duliege AM, Amos CI, et al. High risk of HIV-I infection for first-born twins. Lancet 1991;338:1471-5.
44. 44. European Collaborative Study. Vertical transmission of HIV-I: maternal immune status and obstetric factors. AIDS 1996;10:1675-81.
45. 45. Read J. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies (the International Perinatal HIV Group) [abstract 23275]. Presented at the 12th World AIDS Conference, Geneva, June 1998.
46. 46. Mandelbrot L, Le Chenadec J, Berrebi A, et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998;280:55-60.
47. 47. Centers for Disease Control and Prevention. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep 1998;47: 151-4.